Sanofi | CIK:0001121404 | 3

  • Filed: 3/16/2018
  • Entity registrant name: Sanofi (CIK: 0001121404)
  • Generator: Donnelley Financial Solutions
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1121404/000119312518084834/0001193125-18-084834-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1121404/000119312518084834/sny-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001121404
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory

     

    F/ List of principal companies included in the consolidation during 2017

    F.1. Principal fully consolidated companies

    The table below shows the principal companies and their country of incorporation:

     

    Europe   

    Financial interest (%) as

    of December 31, 2017

    Hoechst GmbH    Germany   100.0
    Zentiva Pharma GmbH    Germany   100.0
    Zentiva Inhalationsprodukte GmbH    Germany   100.0
    Sanofi-Aventis Deutschland GmbH    Germany   100.0
    Aventis Beteiligungsverwaltung GmbH    Germany   100.0
    Genzyme GmbH    Germany   100.0
    Sanofi-Aventis GmbH    Austria   100.0
    Sanofi Belgium    Belgium   100.0
    Sanofi European Treasury Center    Belgium   100.0
    Genzyme Flanders BVBA    Belgium   100.0
    Sanofi-Aventis Denmark A/S    Denmark   100.0
    Sanofi-Aventis SA    Spain   100.0
    Sanofi Oy    Finland   100.0
    Sanofi    France   100.0
    Sanofi-Aventis France    France   100.0
    Sanofi Winthrop Industries    France   100.0
    Sanofi-Aventis Recherche et Développement    France   100.0
    Sanofi-Aventis Groupe    France   100.0
    Sanofi CLIR    France   50.1
    Sanofi Chimie    France   100.0
    Francopia    France   100.0
    Sanofi-Aventis Europe SAS    France   100.0
    Sanofi-Aventis Participations SAS    France   100.0
    Genzyme SAS    France   100.0
    Genzyme Polyclonals SAS    France   100.0
    Sanofi Pasteur (France) SA    France   100.0
    Aventis Pharma SA (France)    France   100.0
    Sanofi-Aventis Am Nord SAS    France   100.0
    Zentiva France    France   100.0
    Aventis Agriculture    France   100.0
    Biopark By Sanofi    France   100.0
    Chattem Greece S.A.    Greece   100.0
    Sanofi-Aventis A.E.B.E    Greece   100.0
    Sanofi-Aventis Private Co, Ltd    Hungary   99.6
    Chinoin Private Co. Ltd    Hungary   99.6
    Carraig Insurance DAC    Ireland   100.0
    Sanofi-Aventis Ireland Ltd    Ireland   100.0

     

     

     

    Europe   

    Financial interest (%) as

    of December 31, 2017

    Genzyme Ireland Limited    Ireland   100.0
    Sanofi Spa    Italy   100.0
    Genzyme Global Sarl    Luxembourg   100.0
    Sanofi-Aventis Norge AS    Norway   100.0
    Sanofi-Aventis Netherlands B.V.    Netherlands   100.0
    Genzyme Europe BV    Netherlands   100.0
    Sanofi-Aventis Sp. z.o.o.    Poland   100.0
    Winthrop Farmaceutica Portugal Lda    Portugal   100.0
    Sanofi Produtos Farmaceuticos Lda    Portugal   100.0
    Zentiva, k.s.    Czech Republic   100.0
    Zentiva Group, a.s.    Czech Republic   100.0
    Sanofi-Aventis, s.r.o.    Czech Republic   100.0
    Sanofi-Aventis Romania SRL    Romania   100.0
    Sanofi-Synthelabo Ltd    United Kingdom   100.0
    Sanofi Pasteur Holding Limited    United Kingdom   100.0
    Chattem Limited (UK)    United Kingdom   100.0
    Sanofi-Aventis UK Holdings Limited    United Kingdom   100.0
    Genzyme Limited    United Kingdom   100.0
    May and Baker Limited    United Kingdom   100.0
    Aventis Pharma Limited    United Kingdom   100.0
    Fisons Limited    United Kingdom   100.0
    Limited Liability Zentiva Pharma    Russia   100.0
    Sanofi-Aventis Vostok    Russia   100.0
    AO Sanofi Russia    Russia   100.0
    Zentiva a.s.    Slovakia   98.9
    Sanofi-Aventis Pharma Slovakia s.r.o.    Slovakia   100.0
    Sanofi AB    Sweden   100.0
    Sanofi SA (Sanofi AG)    Switzerland   100.0
    Sanofi-Aventis (Suisse) SA    Switzerland   100.0
    Pharmaton    Switzerland   100.0
    Zentiva Saglik Urunleri Sanayi ve Ticaret A.S.    Turkey   100.0
    Sanofi-Aventis Ilaclari Limited Sirketi    Turkey   100.0
    Sanofi Pasteur Asi Ticaret A.S.    Turkey   100.0
    Sanofi-Aventis Ukraine    Ukraine   100.0

     

    United States   

    Financial interest (%) as

    of December 31, 2017

    Sanofi US Services Inc    United States   100.0
    Sanofi-Aventis US LLC    United States   100.0
    Sanofi Pasteur Biologics, LLC    United States   100.0
    Chattem, Inc.    United States   100.0

     

     

     

    United States   

    Financial interest (%) as

    of December 31, 2017

    Sanofi Pasteur VaxDesign Corporation    United States   100.0
    Carderm Capital L.P.    United States   100.0
    Aventisub LLC    United States   100.0
    Genzyme Corporation    United States   100.0
    Armour Pharmaceutical Company    United States   100.0
    Sanofi Pasteur Inc.    United States   100.0
    Protein Sciences Corporation    United States   100.0
    Aventis Inc.    United States   100.0
    VaxServe, Inc.    United States   100.0

     

    Other Countries   Financial interest (%) as
    of December 31, 2017
    Sanofi-Aventis South Africa (Pty) Ltd   South Africa   100.0
    Zentiva South Africa (Pty) Ltd   South Africa   100.0
    Sanofi-Aventis Algérie   Algeria   100.0
    Winthrop Pharma Saidal SPA   Algeria   70.0
    Sanofi-Aventis Argentina S.A.   Argentina   100.0
    Genzyme de Argentina SA   Argentina   100.0
    Sanofi-Aventis Healthcare Pty Ltd   Australia   100.0
    Sanofi-Aventis Australia Pty Ltd   Australia   100.0
    Medley Farmaceutica Ltda   Brazil   100.0
    Sanofi-Aventis Farmaceutica Ltda   Brazil   100.0
    Sanofi-Aventis Canada Inc.   Canada   100.0
    Sanofi Consumer Health Inc   Canada   100.0
    Sanofi Pasteur Limited (Canada)   Canada   100.0
    Sanofi-Aventis de Chile SA   Chile   100.0
    Sanofi (Hangzhou) Pharmaceuticals Co., Ltd   China   100.0
    Sanofi (China) Investment Co., Ltd   China   100.0
    Sanofi Beijing Pharmaceuticals Co.Ltd   China   100.0
    Shenzhen Sanofi pasteur Biological Products Co, Ltd   China   100.0
    Winthrop Pharmaceuticals de Colombia SA   Colombia   100.0
    Genfar S.A.   Colombia   100.0
    Sanofi-Aventis de Colombia S.A.   Colombia   100.0
    Sanofi-Aventis Korea Co. Ltd   South Korea   100.0
    Genzyme Korea Co Ltd   South Korea   100.0
    Sanofi-Aventis Gulf FZE   United Arab Emirates   100.0
    Sanofi-Aventis del Ecuador S.A.   Ecuador   100.0
    Sanofi Egypt S.A.E   Egypt   99.8
    Sanofi-Aventis de Guatemala S.A.   Guatemala   100.0
    Sunstone China Limited   Hong Kong   100.0
    Sanofi-Aventis Hong-Kong Limited   Hong Kong   100.0
    Sanofi-Synthelabo (India) Private Ltd   India   100.0
    Sanofi India Limited   India   60.4

     

     

     

    Other Countries   Financial interest (%) as
    of December 31, 2017
    Shantha Biotechnics Private Ltd   India   98.7
    PT Aventis Pharma   Indonesia   80.0
    Sanofi-Aventis Israël Ltd   Israel   100.0
    Sanofi K.K.   Japan   100.0
    SSP Co., Ltd   Japan   100.0
    Winthrop Pharmaceuticals (Malaysia) SDN. BHD.   Malaysia   100.0
    Sanofi-Aventis (Malaysia) SDN. BHD.   Malaysia   100.0
    Sanofi-Aventis Maroc   Morocco   100.0
    Sanofi-Aventis de Mexico S.A de CV   Mexico   100.0
    Sanofi-Aventis Winthrop SA de CV   Mexico   100.0
    Sanofi Pasteur SA de CV   Mexico   100.0
    Sanofi-Aventis Pakistan Ltd   Pakistan   52.9
    Sanofi-Aventis de Panama S.A.   Panama   100.0
    Sanofi-Aventis Latin America SA   Panama   100.0
    Sanofi-Aventis del Peru SA   Peru   100.0
    Genfar Peru S.A.   Peru   100.0
    Sanofi-Aventis Philippines Inc   Philippines   100.0
    Sanofi-Aventis de la Republica Dominicana S.A.   Dominican Republic   100.0
    Sanofi-Aventis Singapore Pte Ltd   Singapore   100.0
    Aventis Pharma (Manufacturing) PTE LTD   Singapore   100.0
    Sanofi Taiwan Co Ltd   Taiwan   100.0
    Zentiva (Thailand) limited   Thailand   100.0
    Sanofi-Aventis Thailand Ltd   Thailand   100.0
    Sanofi-Aventis Pharma Tunisie   Tunisia   100.0
    Winthrop Pharma Tunisie   Tunisia   100.0
    Sanofi-Aventis de Venezuela SA   Venezuela   100.0
    Sanofi-Synthelabo Vietnam   Vietnam   70.0
    Sanofi Vietnam Shareholding Company   Vietnam   100.0

    F.2. Principal investments accounted for using the equity method

     

          Financial interest (%)
    as of December 31, 2017
    Infraserv GmbH & Co. Höchst KG    Germany   31.2
    Bristol-Myers Squibb / Sanofi Canada Partnership    Canada   49.9
    China Resources Sanjiu Sanofi Consumer Healthcare Ltd    China   30.0
    Bristol-Myers Squibb / Sanofi Pharmaceuticals Holding Partnership    United States   49.9
    Bristol-Myers Squibb / Sanofi Pharmaceuticals Partnership    United States   49.9
    Bristol-Myers Squibb / Sanofi Pharmaceuticals Partnership Puerto Rico    United States   49.9
    Bristol-Myers Squibb / Sanofi-Synthélabo Partnership    United States   49.9
    Bristol-Myers Squibb / Sanofi-Synthélabo Puerto Rico Partnership    United States   49.9
    Regeneron Pharmaceuticals, Inc.    United States   22.2
    Onduo LLC    United States   50.0
    Maphar    Morocco   48.3
    Bio Atrium AG    Switzerland   50.0